[Federal Register Volume 86, Number 55 (Wednesday, March 24, 2021)]
[Notices]
[Page 15671]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-06006]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--RFA-IP-21-001, Promoting the Importance of Infant 
and Childhood Vaccination Among Pregnant Women by Prenatal Care 
Providers; and RFA-IP-21-002, US Enhanced Surveillance Network to 
Assess Burden, Natural History, and Effectiveness of Vaccines To 
Prevent Enteric and Respiratory Viruses in Children; Amended Notice of 
Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--RFA-IP-21-001, Promoting the Importance of Infant and Childhood 
Vaccination Among Pregnant Women by Prenatal Care Providers; and RFA-
IP-21-002, US Enhanced Surveillance Network to Assess Burden, Natural 
History, and Effectiveness of Vaccines to Prevent Enteric and 
Respiratory Viruses in Children; April 13-14, 2021, 10 a.m.-5 p.m., 
EDT, Teleconference, Centers for Disease Control and Prevention, Room 
1080, 8 Corporate Square Boulevard, Atlanta, Georgia 30329-4027. The 
meeting was published in the Federal Register on January 11, 2021, 
Volume 86, Number 6, page 1976.
    The meeting is being amended to change the title and meeting date 
of the special emphasis panel from RFA-IP-21-001, Promoting the 
Importance of Infant and Childhood Vaccination Among Pregnant Women by 
Prenatal Care Providers; and RFA-IP-21-002, US Enhanced Surveillance 
Network to Assess Burden, Natural History, and Effectiveness of 
Vaccines to Prevent Enteric and Respiratory Viruses in Children; April 
13-14, 2021, 10 a.m.-5 p.m., EDT to RFA-IP-21-001, Promoting the 
Importance of Infant and Childhood Vaccination Among Pregnant Women by 
Prenatal Care Providers; and RFA-IP-21-003, Collaborative Research on 
Influenza, Coronavirus Disease 2019 (COVID-19), and Other Respiratory 
Pathogens in South Africa; May 13, 2021, 10 a.m.-5 p.m., EDT. The 
meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop US8-1, 
Atlanta, Georgia 30329-4027, (404) 718-8833, [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-06006 Filed 3-23-21; 8:45 am]
BILLING CODE 4163-18-P